Integra LifeSciences Holdings Corp. (IART)
10.81
-0.37
(-3.31%)
USD |
NASDAQ |
Feb 12, 16:00
10.84
+0.03
(+0.28%)
After-Hours: 20:00
Integra LifeSciences Holdings Cash from Investing (Quarterly) : -15.59M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -- |
| Lantheus Holdings, Inc. | -319.47M |
| Organogenesis Holdings, Inc. | -2.235M |
| Biomea Fusion, Inc. | 0.00 |
| Celularity, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 40.91M |
| Cash from Financing (Quarterly) | -10.24M |
| Free Cash Flow | -14.47M |
| Free Cash Flow Per Share (Quarterly) | 0.3355 |
| Free Cash Flow to Equity (Quarterly) | 33.66M |
| Free Cash Flow to Firm (Quarterly) | 47.41M |
| Free Cash Flow Yield | -1.74% |